share_log

Cantor Fitzgerald Reiterates Overweight on Lyra Therapeutics

Moomoo 24/7 ·  Apr 17 09:36

Cantor Fitzgerald analyst Louise Chen reiterates Lyra Therapeutics (NASDAQ:LYRA) with a Overweight.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment